Certified by Founder Lodge
Athernal Bio
United Kingdom - Cambridge
START UP
1 Disclosed Funding Rounds $4,718,630
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Developing targeted immunotherapies to treat high-risk clonal haematopoiesis (CH)—the precursor to blood cancers—so we can stop cancer before it starts.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 02 ,2025 | Unknown | $4,718,630 |
Delin Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Latent | $80,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
games2gether | $5,202,945 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
Avtal | $24,000,000 | (Mar 20, 2026)
